BEDFORD, Mass.--(BUSINESS WIRE)--
Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics
medicines company specializing in therapeutics based on its proprietary hyaluronic
acid ("HA") technology, today announced that its President
and Chief Executive Officer, Charles H. Sherwood, Ph.D., will make a
presentation at the Singular Research Summer Solstice Conference on
Thursday, July 13, 2017 at 9:00 am ET. The conference is being held at
the Metro Meeting Centers in Boston, MA.
A live audio webcast of the presentation may be accessed via the "Investor
Relations" section of Anika's website at www.anikatherapeutics.com.
An audio archive of the presentation also will be available on the
About Anika Therapeutics, Inc.
Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated
orthopedic medicines company based in Bedford, Massachusetts. Anika is
committed to improving the lives of patients with degenerative
orthopedic diseases and traumatic conditions with clinically meaningful
therapies along the continuum of care, from palliative pain management
to regenerative cartilage repair. The Company has over two decades of
global expertise developing, manufacturing, and commercializing more
than 20 products based on its proprietary hyaluronic
acid (HA) technology. Anika's orthopedic medicine portfolio
includes ORTHOVISC®, MONOVISC®,
which alleviate pain and restore joint function by replenishing depleted
HA, and HYALOFAST®,
a solid HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170706005641/en/
For Investor Inquiries:
Anika Therapeutics, Inc.
Chief Financial Officer
Pure Communications, Inc.
Source: Anika Therapeutics, Inc.
News Provided by Acquire Media